|
Volumn 300-302, Issue , 2000, Pages 783-789
|
Is reduction required for antitumour activity of platinum(IV) compounds? Characterisation of a platinum(IV)-nucleotide adduct [enPt(OCOCH3)3(5'-GMP)] by NMR spectroscopy and ESI-MS
|
Author keywords
NMR spectroscopy; Nucleobases; Platinum(IV) complexes; Reduction
|
Indexed keywords
CHEMOTHERAPY;
NUCLEOTIDES;
PLATINUM COMPOUNDS;
% REDUCTIONS;
ANTI-TUMOR CHEMOTHERAPY;
ANTITUMOUR ACTIVITY;
NMR-SPECTROSCOPY;
NUCLEOBASES;
ORAL ADMINISTRATION;
PLATINUM(IV) COMPLEX;
SPECTRA'S;
SYNTHESISED;
TOXIC SIDE EFFECTS;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
ASCORBIC ACID;
GUANOSINE PHOSPHATE;
LIGAND;
NUCLEOTIDE;
PLATINUM COMPLEX;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CHEMICAL REACTION;
COMPLEX FORMATION;
DNA ADDUCT;
DNA DRUG COMPLEX;
DRUG STRUCTURE;
MASS SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PROTON NUCLEAR MAGNETIC RESONANCE;
REDUCTION;
|
EID: 18144433018
PISSN: 00201693
EISSN: None
Source Type: Journal
DOI: 10.1016/S0020-1693(99)00613-1 Document Type: Article |
Times cited : (53)
|
References (14)
|